Eton Pharmaceuticals

ETONNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.222 B

$44.60 -3.42%

Close of 7 Aug 2026

Revenue

$80.0M

#2595 by revenue

Earnings

-$4.60M

Loss-making

Shares outstanding

27,284,491

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#148MannkindMNKD$1.32B
#149Seaport TherapeuticsSPTX$1.26B
#150Eton PharmaceuticalsETON$1.22B
#151Wave Life SciencesWVE$1.20B
#152SavaraSVRA$1.19B

Where these numbers come from

Share counts and financials for Eton Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.